| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |